CESAR L ALVAREZ
CIK 1220297 · last filed 2026-03-16
CESAR L ALVAREZ is a corporate insider who has filed 70 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for PGEN, was dated Mar 16, 2026. Across all open-market trades the lifetime net is −$12.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.17M
7
70
-$12.50M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PGEN | Director | 782,909 | $4.45 | $3.48M | $0 | 15 | 2026-03-16 |
| WSO.B | Director | 0 | $350.00 | $0 | -$5.46M | 8 | 2025-03-07 |
| MD | Director | 48,403 | $24.30 | $1.18M | -$7.13M | 19 | 2020-02-18 |
| PRECIGEN, INC. (XON) Delisted | Director | 125,368 | — | — | $0 | 18 | 2019-03-26 |
| JOE | Director | 4,700 | $64.92 | $305.1K | $89.8K | 5 | 2018-03-19 |
| PDX | Director | 10,000 | $20.85 | $208.5K | $0 | 4 | 2008-05-23 |
| NEW RIVER PHARMACEUTICALS INC (NRPH) Delisted | Director | — | — | — | $0 | 1 | 2007-01-31 |
Recent Filings
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-16 | PGEN | Exer (M) | +71,839 | $0 | EDGAR |
| 2026-03-12 | PGEN | Grant (A) | +17,806 | $62.5K | EDGAR |
| 2025-03-17 | PGEN | Mixed | +123,331 | $62.5K | EDGAR |
| 2025-03-07 | WSO.B | Mixed | +400 | -$611.6K | EDGAR |
| 2024-03-18 | PGEN | Grant (A) | +43,706 | $62.5K | EDGAR |
| 2024-03-12 | PGEN | Exer (M) | +106,837 | $0 | EDGAR |
| 2023-12-14 | WSO.B | Mixed | — | -$1.26M | EDGAR |
| 2023-05-24 | WSO.B | Mixed | — | -$590.1K | EDGAR |
| 2023-03-13 | PGEN | Grant (A) | +53,418 | $62.5K | EDGAR |
| 2023-02-24 | PGEN | Exer (M) | +61,576 | $0 | EDGAR |